Coronavirus disease
Conditions
Interventions
Experimental group:Modern medical basic treatment + Huashan Hospital's No.2 prescription for prevention and treatment of new crowns (Yiqing oral liquid)
Sponsors
Huashan Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients with novel coronavirus infection; 2. Clinical symptoms are asymptomatic and mild; 3. 18 <= age <= 80 years old; 4. Voluntarily sign the written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients taking antiviral drugs (including Chinese patent medicines); 2. Patients with severe or critical novel coronavirus pneumonia; 3. Patients with severe chronic respiratory diseases; 4. TCM syndromes are phlegm-heat obstructing the lung and yang-deficiency-cold coagulation syndrome; 5. Patients with other primary diseases such as digestion, cardiovascular, liver, kidney, nerve, blood, tumor, and mental illness; 6. Those who are allergic or intolerant to Huashan Hospital's No. 2 prescription for the prevention and treatment of the new crown.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| New coronavirus nucleic acid turn negative time;Clinical symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Average length of hospital stay;Anxiety Scale Score; | — |
Countries
China
Contacts
Public ContactDong Jingcheng
Huashan Hospital Affiliated to Fudan University
Outcome results
None listed